Multi-drug resistant tuberculosis among category i treatment failures - a retrospective study

Indian Journal of Tuberculosis

Volumn 61, Issue 2, 2014, Pages 148-151

  Singh, Niti ^a   Sidiq, Zeeshan ^a   Bhalla, Manpreet ^a   Myneedu, V P ^a   Sarin, Rohit ^a  

^a NATIONAL INSTITUTE OF TUBERCULOSIS AND RESPIRATORY DISEASES   (India)

Author keywords

CAT I; DST; Multi drug resistance; Tuberculosis

Indexed keywords

4 NITROBENZOIC ACID; ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE TRANSMISSION; DRUG SENSITIVITY; FEMALE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; RETROSPECTIVE STUDY; SEX DIFFERENCE; SPUTUM ANALYSIS; SPUTUM CULTURE; TREATMENT FAILURE; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

HUMANS; PREVALENCE; RETROSPECTIVE STUDIES; TREATMENT FAILURE; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 84922278623     PISSN: 00195707     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. World Health Organization (WHO) - Global Tuberculosis report 2012.
2. TBC India: TB India 2012: RNTCP Status report. New Delhi. [http://www.tbcindia.org] Central TB division, Directorate General of Health Services, Ministry of Health and Family welfare; Government of India; 2012.
3. Chauhan LS, Agarwal SP. 6. The revised national tuberculosis control programme. In: Agarwal SP, Chauhan LS, editors. Tuberculosis control in India. New Delhi: Elsevier 2005;23-34.
4. Paramsivan CN, Venkataraman: Drug resistance in tuberculosis In India. Indian J Med Res 2004; 120: 377-86.
5. Rodrigues C, Shenai S, Sadani M, Thakkar P, Sodha A, Udwadia Z, Mahashur A, Soman R, Mehta A: Multi drugresistant tuberculosis in Mumbai: it's only getting worse. Int J Tuberc Lung Dis 2006; 10(12): 1421-2.
6. Santha T, Gopi PG, Rajeswari R, Selvakumar N, Subramani R, Chandrasekaran V, Rani B, Thomas A, Narayanan PR: Is it worth treating Category I failure patients with Category I regimen? Indian J Tuberc 2005; 52: 203-6.
7. Vijay S, Bala Sangameshwara VH, Jagannatha PS, Kumar P. Initial drug resistance among tuberculosis patients under DOTS Programme in Bangalore City. Indian J Tuberc 2004; 51: 17-21.
8. Hanif M, Malik S, Dhingra VK. Acquired drug resistance pattern in tuberculosis cases at the State Tuberculosis Centre, Delhi, India. Int J Tuberc Lung Dis 2009; 13: 74-8.
9. Surendra K. Sharma, Sanjeev Kumar, P.K. Saha, Ninoo George, S.K. Arora, Deepak Gupta, Urvashi Singh, M. Hanif, R.P. Vashisht. Prevalence of multidrug-resistant tuberculosis among Category II pulmonary tuberculosis patients. Indian J Med Res 2011; 133: 312-5.
10. Van der Kuyp F, Mahan C. S. Prolonged positivity of sputum smears with negative cultures during treatment for pulmonary tuberculosis. Int J Tuberc Lung Dis 2012: 16(12): 1663-7.
11. Mase S.R, Ramsay A, Ng V, et al. Yield of serial sputum examination in the diagnosis of pulmonary tuberculosis: a systematic review. Int J Tuberc Lung Dis 2007: 11(5): 485-95.
12. Singla R, Singla N, Sarin R, Arora VK. Influence of pre-treatment bacillary load on treatment outcome of pulmonary tuberculosis patients receiving DOTS under Revised National Tuberculosis Control Programme. Indian J Chest Dis Allied Sci 2005; 47: 19-23.